Transactivation/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
promoter/NN
by/IN
human/JJ
herpesvirus/NN
6/CD
(/(
HHV-6/NN
)/)
strains/VBZ
GS/NN
and/CC
Z-29/NN
in/IN
primary/JJ
human/JJ
T/NN
lymphocytes/NNS
and/CC
identification/NN
of/IN
transactivating/VBG
HHV-6/NN
(/(
GS/NN
)/)
gene/NN
fragments/NNS
./.

Human/JJ
herpesvirus/NN
6/CD
(/(
HHV-6/NN
)/)
can/MD
activate/VB
the/DT
human/JJ
immunodeficiency/NN
virus/NN
(/(
HIV/NN
)/)
promoter/NN
and/CC
accelerate/VB
cytopathic/JJ
effects/NNS
in/IN
HIV-infected/JJ
human/JJ
T/NN
cells/NNS
./.
=====
This/DT
study/NN
examines/VBZ
the/DT
regions/NNS
of/IN
the/DT
HIV/NN
promoter/NN
required/VBN
for/IN
HHV-6/NN
transactivation/NN
in/IN
a/DT
heterogeneous/JJ
population/NN
of/IN
primary/JJ
human/JJ
T/NN
lymphocytes/NNS
with/IN
or/CC
without/IN
antigenic/JJ
stimulation/NN
./.
=====
Two/CD
different/JJ
strains/NNS
of/IN
HHV-6/NN
,/,
GS/NN
and/CC
Z29/NN
,/,
transactivated/VBD
the/DT
HIV/NN
promoter/NN
./.
=====
The/DT
GS/NN
strain/NN
transactivated/VBD
the/DT
promoter/NN
in/IN
both/CC
stimulated/VBN
and/CC
resting/VBG
T/NN
cells/NNS
,/,
while/IN
the/DT
Z29/NN
strain/NN
increased/VBD
HIV/NN
promoter/NN
activity/NN
only/RB
in/IN
stimulated/VBN
T/NN
cells/NNS
./.
=====
Three/CD
DNA/NN
clones/NNS
containing/VBG
HHV-6/NN
(/(
GS/NN
)/)
genomic/JJ
fragments/NNS
transactivated/VBD
the/DT
HIV/NN
promoter/NN
in/IN
cotransfected/VBN
T/NN
cells/NNS
./.
=====
A/DT
21.4-kb/JJ
DNA/NN
clone/NN
,/,
pZVB70/NN
,/,
showed/VBD
the/DT
highest/JJS
transactivating/NN
ability/NN
,/,
while/IN
two/CD
other/JJ
DNA/NN
fragments/NNS
,/,
pZVB10/NN
(/(
6.2/CD
kb/NN
)/)
and/CC
pZVH14/NN
(/(
8.7/CD
kb/NN
)/)
,/,
showed/VBD
lower/JJR
activity/NN
./.
=====
One/CD
of/IN
these/DT
clones/NNS
,/,
pZVH14/NN
,/,
activated/VBD
the/DT
HIV/NN
promoter/NN
construct/NN
containing/VBG
a/DT
mutation/NN
in/IN
the/DT
NF/NN
kappa/NN
B/NN
site/NN
./.
=====
However/RB
,/,
this/DT
mutated/VBN
NF/NN
kappa/NN
B/NN
promoter/NN
was/VBD
not/RB
transactivated/VBN
during/IN
HHV-6/NN
(/(
GS/NN
)/)
infection/NN
or/CC
after/IN
cotransfection/NN
with/IN
pZVB70/NN
or/CC
pZVB10/NN
./.
=====
These/DT
data/NNS
indicate/VBP
that/IN
the/DT
NF/NN
kappa/NN
B/NN
sites/NNS
of/IN
the/DT
HIV/NN
promoter/NN
are/VBP
essential/JJ
for/IN
its/PRP$
transactivation/NN
during/IN
HHV-6/NN
(/(
GS/NN
)/)
infection/NN
./.
=====
By/IN
increasing/VBG
HIV/NN
promoter/NN
activity/NN
in/IN
primary/JJ
T/NN
lymphocytes/NNS
,/,
HHV-6/NN
may/MD
consequently/RB
increase/VB
HIV/NN
replication/NN
,/,
leading/VBG
to/TO
an/DT
increase/NN
in/IN
the/DT
cytopathic/JJ
effect/NN
on/IN
coinfected/VBN
human/JJ
T/NN
cells/NNS
./.